Overview

Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia

Status:
Terminated
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
It is hypothesized that SPS is more effective than placebo control (alternative hypothesis) in lowering i-STAT potassium levels in subjects with i-STAT potassium levels between 5.0 - 6.5 mmol/l versus no difference between SPS and placebo control (null hypothesis).
Phase:
Phase 4
Details
Lead Sponsor:
ZS Pharma, Inc.
Treatments:
Polystyrene sulfonic acid